Abstract
Objectives/Hypothesis: To evaluate the risk of post‐tonsillectomy hemorrhage associated with perioperative ketorolac use.Study Design: Systematic review and meta‐analysis of primary articles reporting individual‐level post‐tonsillectomy hemorrhage rates in subjects receiving perioperative ketorolac and matched controls. Retrospective and prospective studies were both included.Methods: PubMed search was performed for “[ketorolac OR toradol] AND tonsillectomy.” Articles fulfilling inclusion criteria were subjected to meta‐analysis to determine summary relative risk (RR).Results: Adults are at five times increased risk for post‐tonsillectomy hemorrhage with ketorolac use (RR: 5.64; 95% confidence interval [CI]: 2.08–15.27; P < .001). In contrast, children under 18 are not at statistically significantly increased risk (RR: 1.39; 95% CI: 0.84–2.30; P = .20). Both retrospective and prospective studies yield consistent findings. There is no association of RR with pre‐ or postoperative administration of ketorolac.Conclusions: Ketorolac can be used safely in children, but is associated with a five‐fold increased bleeding risk in adults.Level of Evidence: NA Laryngoscope, 124:1789–1793, 2014

This publication has 14 references indexed in Scilit: